Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPKAPK5 | Q8IW41 | 2/20 | 0.49 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.44 |
| ▸ | MET | P08581 | 1/20 | 0.43 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.43 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 3/20 | 0.42 |
| ▸ | TTK | P33981 | 1/20 | 0.42 |
| ▸ | MAPKAPK2 | P49137 | 6/20 | 0.41 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CCNK | O75909 | 1/20 | 0.41 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.41 |
| ▸ | CDK2 | P24941 | 1/20 | 0.41 |
| ▸ | CCND3 | P30281 | 1/20 | 0.41 |
| ▸ | CDK9 | P50750 | 1/20 | 0.41 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25822689 | 0.87 | MAPKAPK5 (0.51) | MAPKAPK5STK17AEGFRMAPKAPK2MAP4K1 | |
| SCHEMBL25822741 | 0.87 | SYK (0.51) | MAPKAPK5LRRK2EGFR | |
| SCHEMBL25822740 | 0.84 | MAPKAPK5 (0.51) | MAPKAPK5STK17AEGFRMAPKAPK2MAPT | |
| SCHEMBL25822683 | 0.83 | MAPKAPK5 (0.54) | MAPKAPK5MAP4K4METLRRK2STK17A | |
| SCHEMBL25822737 | 0.82 | MAPKAPK5 (0.42) | MAPKAPK5MAP4K4EGFRMAPKAPK2MAP4K1 | |
| SCHEMBL25822735 | 0.80 | MAPKAPK5 (0.52) | MAPKAPK5EGFRMAPKAPK2MAPT | |
| SCHEMBL25823381 | 0.78 | MAPKAPK5 (0.50) | MAPKAPK5EGFRMAPKAPK2 | |
| SCHEMBL25823409 | 0.78 | MAPKAPK5 (0.43) | MAPKAPK5STK17AEGFRMAPKAPK2MAPT | |
| SCHEMBL25823182 | 0.76 | SYK (0.49) | MAPKAPK5 | |
| SCHEMBL25822675 | 0.73 | MAPKAPK5 (0.67) | MAPKAPK5LRRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219960-A1 | 1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2 | OCUMENSION THERAPEUTICS (SUZHOU) CO., LTD. (CN) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219960-A1 | 1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2 | SYK, KDR, FLT1 | MAPKAPK5 216/4885MAP4K4 543/4885MET 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.